Structure Therapeutics (GPCR) Highlights Two Aleniglipron Posters at ObesityWeek 2026, Focusing on ACCESS Trial Data
Market Chameleon (Tue, 20-Oct 11:30 AM)
Structure Therapeutics (GPCR) Sets Two ObesityWeek 2026 Posters Around Aleniglipron’s ACCESS Trials
Market Chameleon (Tue, 20-Oct 8:20 AM)
